VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published on Nov 26th-28th; they will resume
distribution on Monday, Dec 1st.
|
|
| November
25, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Ascentage Pharma: Publication of
Olverembatinib Phase Ib Safety, Efficacy and
Novel Mechanism Data in Gastrointestinal
Stromal Tumors in Nature’s Signal
Transduction and Targeted Therapy More
- Johns Hopkins Medicine: Novel Liver
Cancer Vaccine Achieves Responses in Rare
Disease Affecting Children and Young Adults
More
- Longhorn Vaccines & Diagnostics:
PrimeStore MTM Validated With New Data for
Large-Scale, Global TB Screening More
|
|
|
|
- Get Discounted Access to Exclusive
VC Funding Data from BYTE51
More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
- More on AstraZeneca Expanding
Biomanufacturing in Maryland, US More
|
|
|
| Struggling
to get attention for your
products and services?
Break through with high-impact
marketing content and campaigns |
|
Learn More
→ |
|
|
- Clinical Trial Using Focused Ultrasound With
Chemotherapy Finds Potential Survival Benefit
for Brain Cancer Patients More
- Fast-Freezing Brain Signals Sheds Light on
Human Synapses More
- FDA’s Pazdur Questions Legality of Voucher
Program, Sources Say, in Latest Internal
Disagreement More*
- Health Security for Children: Inside
the SPARK Accelerator With AcQumen Medical
and Vesynta Podcast
- In Lethal Influenza, Repair the Lung Before
It’s Too Late More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: How NAMs Are Rewriting the Rules of
Antibody Discovery
Podcast
|
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
|
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- Empowering Futures: Montgomery
College’s Biotech Boot Camp Wraps Up With a
Strong Finish More
- Hiring Outlook: Job Openings Will Likely
Drop as 2025 Winds Down But Could Rise in 2026
More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- Jeff Bluestone, Stephen Dilly Talk CEO
Handoff, What’s Next for Sonoma; Scott
Gottlieb’s Next Move More*
|
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Compounding
Pharmacy Compliance (Save 10% with VIP code:
25B4B10) Dec
9-10
- PBM Contracting Summit (Save 10% with VIP
code: 25B4B10) Dec
9-10
- Trade
and Channel Strategies (Save 10% with VIP
code: 25B4B10) Dec
9-11
- The Power of Presenting at Biotech Showcase
Dec 10
- Advancing
Drug Development Forum Dec
11
- Know
Before You Go: AI in 2026 — Signals,
Risks, and Real-World Impact (Pre-JPM
Event) Jan
6
- BLPN
Investor Summit Jan
8-10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|